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Behavioral/Cognitive
Hypoactivation of CRF Receptors, Predominantly Type 2, in
the Medial-Posterior BNST Is Vital for Adequate Maternal
Behavior in Lactating Rats
Stefanie M. Klampfl,1 Paula J. Brunton,2Doris S. Bayerl,1 and Oliver J. Bosch1
1Department of Behavioural and Molecular Neurobiology, University of Regensburg, 93053 Regensburg, Germany, and 2Division of Neurobiology, The
Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, United Kingdom
Maternal behavior ensures the proper development of the offspring. In lactatingmammals, maternal behavior is impaired by stress, the
physiological consequenceof central corticotropin-releasing factor receptor (CRF-R)activation.However,whichCRF-Rsubtype inwhich
specific brain area(s) mediates this effect is unknown. Here we confirmed that an intracerebroventricularly injected nonselective CRF-R
antagonist enhances, whereas an agonist impairs, maternal care. The agonist also prolonged the stress-induced decrease in nursing,
reducedmaternal aggression and increased anxiety-relatedbehavior. Focusing on thebednucleus of the stria terminalis (BNST), CRF-R1
andCRF-R2mRNAexpression did not differ in virgin versus lactating rats. However, CRF-R2mRNAwasmore abundant in the posterior
than in the medial BNST. Pharmacological manipulations within the medial-posterior BNST showed that both CRF-R1 and CRF-R2
agonists reduced arched back nursing (ABN) rapidly and after a delay, respectively. After stress, both antagonists prevented the stress-
induceddecrease in nursing, with theCRF-R2 antagonist actually increasingABN.During thematernal defense test,maternal aggression
was abolished by theCRF-R2, but not the CRF-R1, agonist. Anxiety-related behaviorwas increased by theCRF-R1 agonist and reduced by
both antagonists. Both antagonists were also effective in virgin females but not inmales, revealing a sexual dimorphism in the regulation
of anxiety within the medial-posterior BNST. In conclusion, the detrimental effects of increased CRF-R activation onmaternal behavior
are mediated via CRF-R2 and, to a lesser extent, via CRF-R1 in the medial-posterior BNST in lactating rats. Moreover, both CRF-R1 and
CRF-R2 regulate anxiety in females independently of their reproductive status.
Introduction
The maternal brain is a complex and perfectly organized system
that undergoes vital adaptations peripartum to ensure the onset
andmaintenance ofmaternal behavior (Bosch, 2011). Therefore,
maladaptive alterations can cause severe problems such as in-
creased vulnerability to mood disorders, which affect 20–30% of
mothers (Brummelte and Galea, 2010). One factor that evidently
contributes to such maladaptations is corticotropin-releasing
factor (CRF; Magiakou et al., 1996; O’Keane et al., 2011).
CRF is a 41 amino acid neuropeptide that binds to the CRF
type-1 receptor (CRF-R1) and has 40-fold lower affinity to
CRF-R2 (Hauger et al., 2003), which is primarily activated by
urocortin 2 (Ucn 2) and Ucn 3 (Hsu and Hsueh, 2001; Lewis et
al., 2001; Reyes et al., 2001). CRF is the primary initiator of the
hypothalamo-pituitary-adrenal axis (Vale et al., 1981). Further-
more, CRF exerts anxiogenic actions via CRF-R1 when centrally
injected (Koob and Thatcher-Britton, 1985; Bruchas et al., 2009)
or locally injected, for example, into the bed nucleus of the stria
terminalis (BNST) of male rats (Lee and Davis, 1997; Liang et al.,
2001; Sahuque et al., 2006). The CRF system also modulates male
social behaviors including aggression (Mele et al., 1987; Tazi et al.,
1987) and social recognition (Heinrichs, 2003). In females, activated
CRF-Rs impair maternal behavior, as reported in a few studies in
rodents (Pedersen et al., 1991; Gammie et al., 2004; D’Anna et al.,
2005;D’AnnaandGammie, 2009;Klampfl et al., 2013) andprimates
(Saltzman et al., 2011). In lactating mice, intracerebroventricular
administration of CRF or Ucn 3 decreases maternal aggression
(Gammie et al., 2004; D’Anna et al., 2005), which has been linked to
CRF-R2 activation in the lateral septum (D’Anna and Gammie,
2009). In ovariectomized, steroid-primed virgin rats, intracerebro-
ventricular CRF decreases maternal-like behavior and induces pup
killing (Pedersen et al., 1991), which is not observed in lactating rats
(Klampfl et al., 2013). In the latter, intracerebroventricular CRF-
R1/2activationdecreasesmaternal careandaggressionand increases
anxiety-relatedbehavior,whereasCRF-R1/2 inhibition restoresma-
ternal care after stress and is anxiolytic (Klampfl et al., 2013). How-
ever, the potential brain sites of action and the specific role of the
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different CRF-R subtypes in maternal behavior and anxiety-related
behavior in lactating rats are not known.
Here, we first aimed to confirm our finding of impaired ma-
ternal behavior after central manipulation of CRF-R1/2 (Klampfl
et al., 2013) using a different, more nonspecific receptor agonist.
Thereafter, we focused on the BNST, a key brain region for ma-
ternal behavior (Terkel et al., 1979; Numan et al., 1985) and
anxiety behavior (Lee and Davis, 1997), which expresses most
members of the CRF family (Potter et al., 1992; Potter et al., 1994;
Li et al., 2002). We assessed CRF-R1 and CRF-R2mRNA expres-
sion in the medial (mBNST) and posterior (pBNST) BNST of
virgin and lactating rats. Basedon these results, we studiedmaternal
care, motivation, aggression, and emotionality in lactating rats after
local pharmacologicalmanipulationwithCRF-R1 andCRF-R2 spe-
cific agonists/antagonists in themedial-posterior BNST (mpBNST).
In addition, we investigated a potential sexual dimorphism in the
regulation of anxiety-related behavior within the mpBNST in rats.
Materials andMethods
Animals
Virgin female or male Wistar rats (220–250 g; Charles River Laborato-
ries) were kept under standard laboratory conditions (change of bedding
once per week, 12/12 h light/dark cycle, lights on at 6:00 A.M., room
temperature 22 2°C, 55% relative humidity) with access to water and
standard rat chow ad libitum. For Experiments 1–3, females were mated
and housed until delivery as described previously (Klampfl et al., 2013).
Litters were culled to eight pups ofmixed sexes. For comparison of virgin
females versus lactating rats in Experiment 2, both groups were treated
identically; that is, virgins were single housed 7 d before brain removal,
consistent with the single-housing period of the lactating rats. For Exper-
iments 4 and 5, virgin female and male rats were kept in groups of 3–4
until surgery, whereafter they were single housed as described previously
(Klampfl et al., 2013). During the single-housing period, all rats were
handled twice a day to reduce nonspecific stress responses during the
experiments (Neumann et al., 1998).
For the maternal defense test, naive virgin female rats (200–220 g;
Charles River Laboratories) were used as intruders at random stages of
their estrus cycle. Intruder rats were kept in a separate room to avoid
olfactory recognition.
The experiments were approved by the Committee on Animal Health
and Care of the local government and conformed to international guide-
lines on the ethical use of animals. All efforts were made to minimize the
number of rats used and their suffering.
Behavioral tests
Maternal care. Maternal care was monitored on lactation day 1 (LD1)
before and after substance infusion under nonstress conditions and on
LD5 before and after substance infusion, which was combined with a
psychosocial stressor (stress conditions; i.e., maternal defense test; Neu-
mann et al., 2005). We acknowledge that there is a limited amount of
stress associated with the infusion procedure, though the nonstress term
is used to distinguish between the observations made on LD1, which did
not involve the maternal defense test, from those conducted on LD5,
which did. Observations were conducted for 10 s every second min in 30
min blocks according to an established protocol (Bosch and Neumann,
2008). On LD1, dams were observed from 8:00–9:00 A.M., infused at
9:00 A.M., and observation continued from 9.30–11:00 A.M. In addi-
tion, dams were observed from 2:00–3:00 P.M. to assess potential long-
lasting effects of drug treatment. On LD5, dams were observed from
8:00–9:00 A.M., transported to another room, and infused at 10:00 A.M.
Dams were tested 30 min after infusion in the maternal defense test,
transported back to the observation room immediately afterward, and
maternal care was observed for another 60 min to assess potential effects
of the stressor on maternal care. The main parameter for the quality of
maternal care was the occurrence of arched back nursing (ABN; Bosch,
2011; Bosch and Neumann, 2012), the only active nursing posture in
which the dam is engaged in a quiescent kyphosis (Stern and Johnson,
1990). Other nursing parameters scoredwere hovering over the pups and
blanket nursing posture, which together with ABN were counted as the
sum of nursing, indicating the quantity of maternal care because both
active and passive nursing postures were included. Pup retrieval/mouth-
ing and licking/groomingwere assessed as “othermaternal behaviors.” In
addition, the following nonmaternal behaviors were scored: locomotion
(including digging/burrowing and cage exploration), self-grooming, and
sleeping/resting, which were summed up and are presented as “off-nest”
behavior. Data are shown in 30 min blocks before and after treatment
infusion with a maximal count of 15 observations per block.
Maternal motivation.The dams’maternal motivation was tested in the
pup retrieval test (PRT) on LD2 (van Leengoed et al., 1987; Neumann et
al., 2005). The dams were separated from their litter 60 min before the
test and moved to a separate room. Thirty minutes before the test, dams
received their respective treatment. All eight pups of the litter were then
distributed in a plastic box (54 34 31 cm) coveredwith bedding from
their home cage, the mother was placed in the box, and the number of
retrieved pups within the 15 min testing period was counted.
Maternal aggression. To assess maternal aggression, the maternal de-
fense test was performed on LD5 in a separate room, to which the dams
were transported 60 min before the test (see Maternal care, above).
Thirtyminutes after treatment infusion, the lactating residents were con-
frontedwith anunknownvirgin female intruder in their home cage in the
presence of the litter for 10min, as described previously (Neumann et al.,
2001; Bosch et al., 2005). The dam’s behavior was videotaped for subse-
quent analysis by an experienced observer blinded to the treatment. The
following behavioral parameters were scored: total number of attacks,
latency to first attack, keep down, lateral threat, and offensive upright,
and nonaggressive behaviors (for detailed description, see Bosch, 2013).
Anxiety-related behavior. Anxiety-related behavior was tested on the ele-
vated plus maze (EPM) on LD3 in lactating rats and additionally in virgin
female andmale rats as described previously (Pellow et al., 1985; Neumann
et al., 2000). Male rats were also tested in the light dark box (LDB; adapted
fromWaldherr and Neumann, 2007; Slattery and Neumann, 2010).
The EPM consists of two open arms (50  10 cm, 80 lux) and two
closed arms (50  10  30 cm, 10 lux) connected by a square-shaped
neutral zone (10 10 cm, 65 lux) and is elevated 82 cm from the floor.
The rats were placed in the neutral zone of the maze and were allowed to
freely explore the maze for 5 min. The percentage of time spent on the
open arms (ratio of time spent on open arms to total time spent on all
arms) and the percentage of open arm entries (ratio of entries into open
arms to total number of entries into all arms) were taken as an indicator
of anxiety-related behavior. An entry was recorded when both front legs
and shoulders of the rat crossed into an arm or the neutral zone. Because
the rat always had to cross the neutral zone, every open/closed arm entry
was considered as a new entry. The number of closed arm entries was
used to measure locomotion (Neumann et al., 2000).
TheLDBconsistsof a light (4050cm,400 lux)andadarkcompartment
(40  30 cm, 50 lux). A small opening (7.5  7.5 cm) connecting both
compartments enables transition between the light and dark box. The floor
in each compartment is divided into squares (10 10 cm) to assess locomo-
tor activity via line crosses. The ratswere placed in the light box and the time
spent in each box, latency to enter the dark box and to reenter the light box,
line crosses, and rearings were assessed during the 5min test.
Experimental design
Experiment 1: Nonspecific intracerebroventricular manipulation of CRF-
R1/2 in lactating rats. On pregnancy day 18 (PD18), females were im-
plantedwith a 21G guide cannula targeting the right lateral ventricle (1.0
mm caudal, 1.6 mm lateral, 1.8 mm ventral to bregma; Paxinos and
Watson, 1998) under inhalation anesthesia (isoflurane; BaxterGermany)
and semisterile conditions as described previously (Bosch et al., 2010).
On the experimental days, a 23G infusion cannula, prepared as described
previously (Neumann et al., 2000), was used to infuse the following:
vehicle (VEH; 5 l of sterile Ringers solution  4% DMSO; pH 7.4;
Braun), the nonspecific CRF-R1/2 agonist Ucn 1 (1g/5l; Bachem), or
the nonspecific CRF-R1/2 antagonist D-Phe (D-Phe12, Nle 21,38, -Me-
Leu37)-CRF (12–41, human/rat; 10 g/5 l; Bachem). Doses were cho-
sen based on previous studies (Jones et al., 1998; Gammie et al., 2004).
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On LD1, LD2, LD3, and LD5, lactating dams received a single acute
intracerebroventricular infusion 30 min before the tests. Each animal
received the same treatment on every testing day as assigned on the first
testing day. In each case, dams were immediately returned to their home
cage after infusion. Maternal care was observed under nonstress condi-
tions (LD1) and stress conditions (LD5) in the home cage, as described in
Maternal care, above. In addition, maternal motivation (LD2), anxiety-
related behavior (LD3), and maternal aggression (LD5) were tested as
described in Behavioral tests, above. All tests were performed between
8:00 A.M. and 3:00 P.M. in the light phase of the cycle.
Experiment 2: Expression of CRF-R1 andCRF-R2mRNAwithin the BNST
of virgin versus lactating rats. To comparemRNA expression of CRF-R1 and
CRF-R2 between virgin and lactating rats, two separate groups of untreated
rats were killed by conscious decapitation under basal conditions on LD4 or
equivalent in virgin rats. The brains were rapidly removed, flash frozen on
dry ice, and stored at20°C until subsequent processing by in situ hybrid-
ization, as described in In situ hybridization, below.
Experiment 3: Intra-mpBNST manipulation of CRF-R1 or CRF-R2 in
lactating rats. On PD18, females were implanted bilaterally with 23 G
guide cannula targeting the pBNST (0.7 mm caudal, 1.5 mm lateral, 4.5
mm ventral to bregma; Paxinos and Watson, 1998). Substances were
infused using a 27 G infusion cannula (Neumann et al., 2000). Lactating
rats received the following: VEH (0.5l of sterile Ringer’s solution 4%
DMSO; pH 7.4; Braun), CRF-R1 agonist human/rat CRF (1 g/0.5 l;
Tocris Bioscience), CRF-R1 specific antagonist CP-154,526 (12 g/0.5
l; Tocris Bioscience), CRF-R2 specific agonist hUcn 3 (stresscopin; 3
g/0.5 l; Phoenix Pharmaceuticals), or CRF-R2 specific antagonist
Astressin-2B (4 g/0.5 l; Sigma-Aldrich). Doses were chosen based on
previous studies (Gammie et al., 2004;D’Anna et al., 2005; Sahuque et al.,
2006; D’Anna and Gammie, 2009). To assess how far the drug diffused
from the injection site, ink was infused (Pelikan ink 4001 diluted 1:20 in
Ringer’s solution) into the pBNST of three rats and the brains were
collected for histological analysis. Because ink injected into the pBNST
was also detected in the mBNST, we defined the treatment-affected re-
gion as the mpBNST. All rats were infused 30 min prior to testing. As-
sessment of behaviors on LD1, LD3, and LD5 were conducted as
described in Behavioral tests, above. Importantly, the repeated acute
infusion of the CRF-R1 or CRF-R2 agonist/antagonist separated by 48 h
intervals and at the doses used here is not expected to result in receptor
(de)sensitization (Prof. J. Radulovic, Northwestern University, personal
communication; see also Spiess et al., 1998; Hauger et al., 2009). More-
over, in vitro studies have demonstrated rapid (within 1–2 h) resensiti-
zation of the CRF-R after CRF-induced receptor internalization (Hauger
et al., 2009). A different set of lactating dams was used for the PRT on
LD2. All tests were performed between 8:00 A.M. and 3:00 P.M.
Experiment 4: Intra-mpBNST manipulation of CRF-R1 or CRF-R2 in
virgin rats. Virgin rats underwent the same surgery as females in Experi-
ment 32 weeks after arrival. Starting 3 d after surgery, vaginal smears
were taken to assess estrus cycle stage. Females in metestrus were tested
the following day (i.e., presumed to be diestrus) on the EPM between
8:00 A.M. and 12:00 P.M. The females were placed on the EPM 10 min
after intra-mpBNST manipulation with VEH, CP-154,526, or
Astressin-2B (for details, see Experiment 3, above) to determine whether
the effects of CRF-R manipulation on anxiety in lactating rats are sex or
lactation specific, because anxiety-related behavior of male rats is seem-
ingly modulated only by CRF-R1 manipulation (Sahuque et al., 2006).
After the test, estrus cycle stage was verified via a vaginal smear and virgin
rats not in diestrus were omitted from the data analysis.
Experiment 5: Intra-mpBNST manipulation of CRF-R1 or CRF-R2 in
male rats. Recently, the effects of CRF-R manipulation in the BNST on
male anxiety were reported (Sahuque et al., 2006). Because numerous
subdivisions of the BNST were manipulated at the same time in that
study, here, we focused exclusively on the mpBNST to assess clearly a
potential sexual dimorphic effect of CRF in regulating anxiety in this
subdivision of the BNST. Therefore, male rats were implanted bilaterally
with cannula targeting the pBNST 2 weeks after arrival at our animal
facility (for details, see Experiment 3). Six days after surgery, the males
were administered VEH, CRF, or stresscopin into the mpBNST (for de-
tails, see Experiment 3) and were placed 10 min (VEH, CRF) or 25 min
(stresscopin) after infusion on the EPM. Two days later, the males were
placed in the LDB after infusion with the same treatments as assigned for
the EPM. In a different set of animals, we tested whether the application
of CRF-R antagonists per se has anxiolytic effects, as was shown for
females (see Experiment 3 and 4). Therefore, males were placed on the
EPM 10 min after intra-mpBNSTmanipulation with VEH, CP-154,526,
or Astressin-2B (for details, see Experiment 3) using the same doses as for
virgin and lactating females.
Histology
At the end of the behavioral experiments, rats were decapitated. For intrace-
rebroventricular cannula verification, brains were infused with blue ink, re-
moved, andcutwitha razorbladeat the infusionsite.Blue-coloredventricles
indicated correct placement of the intracerebroventricular cannula (Exper-
iment 1). To verify the correct placements of local cannula within the
mpBNST, brains were removed, flash frozen, cut into 40 m coronal sec-
tions, slidemounted, and stainedviaquickNissl staining (Experiments 3–5).
In situ hybridization for CRF-R mRNA expression
Brains were sectioned at 16 m using a cryostat (CM3050S; Leica), slide
mounted, and stored at20°C until further processing.
CRF-R1/2mRNA in situhybridizationwas conducted following anestab-
lished protocol and using previously described riboprobes for CRF-R1 or
CRF-R2 (Brunton et al., 2009; Brunton et al., 2011) kindly provided by Dr.
Nicholas Justice (Salk Institute, La Jolla, CA). Some extra slides were also
hybridized with 35S-UTP-labeled cRNA sense probes to serve as negative
controls. Autoradiograms of the mBNST (bregma0.2 mm to0.4 mm)
and thepBNST(bregma0.4mmto0.9mm;Paxinos andWatson, 1998)
were examinedwith ImageJ version1.46by an experiencedobserver blinded
to the groups, as described previously (Brunton et al., 2011). In addition, all
pictures were converted to 8 bit and their contrast was enhanced to the
same extent. Measurements were made bilaterally over 6 sections per
rat. Brain sections hybridized with 35S-UTP-labeled cRNA sense
probes showed no signal above background.
Statistical analysis
In situ hybridization data were analyzed using a two-way ANOVA (fac-
tors: reproductive status  brain site). For the behavioral studies, only
animals that had been fitted correctly with the local cannula were in-
cluded in the analysis. Behavioral data were analyzed using either one-
way ANOVA (factor: treatment) or ANOVA for repeated measures
(factors: time  treatment). One-way ANOVA was followed by SIDAK
and ANOVA for repeated measures by Fisher’s LSD post hoc test. For all
tests, the software package SPSS 19.0 was used. Data are presented as
means SEM and significance was accepted at p 0.05.
Results
Experiment 1: Behavioral effects of nonspecific
intracerebroventricular manipulation of CRF-R1/2 in
lactating rats
Maternal care under nonstress conditions on LD1
ABN. Neither significant differences depending on time and/or
treatment nor an interaction were revealed by two-way ANOVA
for repeated measures (Fig. 1A, top).
Nursing. Differences in nursing, which comprises all nursing
positions, were found depending on treatment (two-way
ANOVA for repeated measures; F(2,16) 4.17, p 0.03), but not
on time. However, there was a significant time  treatment in-
teraction (F(8,64)  2.20, p  0.03; Fig. 1A, bottom). No group
differenceswere detected before treatment infusion. The infusion
procedure decreased the occurrence of nursing in VEH-treated
dams significantly (p  0.01) and there was a tendency for a
reduction in the CRF-R1/2-agonist-treated dams (p 0.07) at t
30 min. The CRF-R1/2 antagonist prevented this infusion-
induced decrease at t30 min (p 0.01) while the agonist even
prolonged the impairing effect on nursing at t 90 min (p 
0.01) compared with VEH. In the afternoon, the occurrence of
nursing did not differ between the groups (data not shown).
Klampfl et al. •mpBNST CRF-R Activation Impairs Maternal Behavior J. Neurosci., July 16, 2014 • 34(29):9665–9676 • 9667
Other maternal behaviors. No significant differences or inter-
actions depending on time and/or treatment were found in lick-
ing/grooming and pup retrieval/mouthing (data not shown).We
did not observe any pup killing following any of the treatments.
Nonmaternal behaviors. A significant interaction was found in
the occurrence of off-nest behavior (two-way ANOVA for re-
peatedmeasures; F(8,68) 2.20, p 0.03; Table 1). No differences
were found depending on time or treatment. VEH-treated dams
showed off-nest behavior more frequently at t 30 min com-
pared with before infusion (p  0.01) and with CRF-R1/2-
antagonist-treated dams (p  0.04). CRF-R1/2-agonist-treated
dams showed differences in self-grooming depending on treatment
(F(2,17)  10.27, p 	 0.01), but not on time. No interaction was
detected between the two factors. These dams showed significantly
more self-grooming than VEH-treated dams (p	 0.01). No differ-
ences were detected for locomotion and sleeping/resting.
Figure 1. Effect of nonspecific intracerebroventricular CRF-R1/2manipulation onmaternal care under nonstress conditions on LD1 (A) and stress conditions on LD5 (B), onmaternal aggression
during the maternal defense test on LD5 (C), and on anxiety-related behavior of lactating rats on LD3 (D). ABN (A, B, top) and sum of nursing (A, B, bottom) were scored for 60 min before and for
90min after infusion (A) or 60min aftermaternal defense (B). Maternal aggressionwas scored as number of attacks (C, top) and attack latency (C, bottom) by the resident. Anxiety-related behavior
wasmeasured as the percentage of time spent on the open arms (D, top) and the percentage of entries into the open arms (D, bottom) on the EPM. Dams received an acute intracerebroventricular
infusion of VEH (5l of sterile Ringer’s solution, pH 7.4), CRF-R1/2 agonist Ucn 1 (CRF-R1/2 ago; 1g/5l), or CRF-R1/2 antagonist D-Phe (CRF-R1/2 ant; 10g/5l). Data are presented asmean
 SEM. n 6–7 per group. **p 0.01, *p 0.05, (*) p 0.06 versus VEH;p 0.01, ()p 0.07 versus previous time point (two-way ANOVA for repeatedmeasures; factors: time
treatment).
Table 1. Effects of nonspecific icv CRF-Rmanipulation on nonmaternal behaviors under nonstress conditions on LD 1
Behavior Group
Occurrence (n)
60 min 30 min  30 min 60 min 90 min
Off-nest VEH 0.5 0.5 0.0 0.0  4.0 2.4 2.5 1.8 2.8 1.2
CRF-R1/2 ago 0.2 0.2 0.8 0.3  1.5 0.8 1.2 1.0 3.5 1.5
CRF-R1/2 ant 0.4 0.2 0.9 0.6  0.0 0.0* 1.1 0.6 0.4 0.4
Locomotion VEH 0.5 0.5 0.0 0.0  1.5 0.9 0.3 0.2 0.0 0.0
CRF-R1/2 ago 0.0 0.0 0.5 0.2  0.5 0.3 0.7 0.5 1.3 0.6
CRF-R1/2 ant 0.3 0.2 0.3 0.2  0.0 0.0 0.3 0.2 0.1 0.1
Self-grooming VEH 0.0 0.0 0.0 0.0  0.2 0.2 0.0 0.0 0.2 0.2
CRF-R1/2 ago ## 0.2 0.2 0.3 0.2  1.0 0.5 0.3 0.3 0.8 0.4
CRF-R1/2 ant 0.0 0.0 0.1 0.1  0.0 0.0 0.3 0.2 0.0 0.0
Sleeping/resting VEH 0.0 0.0 0.0 0.0  2.3 2.3 1.8 1.8 0.8 0.8
CRF-R1/2 ago 0.0 0.0 0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0
CRF-R1/2 ant 0.0 0.0 0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0
ago, Agonist; ant, antagonist.
Theoccurrence of all off-nest behaviorswas scored for 60minbefore and for 90min after infusion (indicatedby thedotted line). Off-nest behavior is further divided into locomotion (includingdigging/burrowingandany explorative behavior
in the home cage), self-grooming, and sleeping/resting. For details on treatments, see legend to Figure 1. Data are presented asmean SEM. n 6–7 per group. *p 0.05 versus VEH;p 0.05 versus previous time point (two-way
ANOVA for repeated measures; factors: time treatment); ##p 0.01 versus VEH (two-way ANOVA for repeated measures; factor: treatment).
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Maternal care under stress conditions on LD5
ABN. Differences in ABN were found depending on time
(ANOVA for repeated measures; F(3,48) 6.32, p	 0.01; Fig. 1B,
top), but not on treatment.No interactionwas foundbetween the
two factors.
Nursing. Differences in nursing were found depending on
time (two-way ANOVA for repeated measures; F(3,48)  46.09,
p	 0.01; Fig. 1B, bottom), but not on treatment. No interaction
effect was found between the two factors. However, analysis of
the within-subject contrasts revealed a significant linear interac-
tion between the treatment groups at various time points (two-
way ANOVA for repeated measures, F(2,16) 4.09, p 0.03). In
all three groups, nursing was decreased at t 0 min compared with
all other intervals (VEH: p 	 0.01, in each case; CRF-R1/2 ago-
nist: t 130 min/t 100 min: p 	 0.01, t 30 min: p  0.04;
CRF-R1/2 antagonist: p	 0.01, in each case). Furthermore, CRF-
R1/2 agonist-treated dams showed less nursing at t 30 min
compared with VEH-treated mothers (p 0.05).
Other maternal behaviors. No significant differences or inter-
actions depending on time and/or treatment were found in pup
retrieval/mouthing and licking/grooming (data not shown). We
did not observe any pup killing after any of the treatments.
Nonmaternal behaviors. All dams showed differences in the
occurrence of off-nest behavior (two-way ANOVA for repeated
measures; F(3,51)  30.92, p 	 0.01), in locomotion (F(3,51) 
50.14, p	 0.01), and in sleeping/resting (F(3,51) 4.54, p	 0.01)
depending on time but not on treatment (Table 2). No interac-
tions between the two factors were detected. Significant interac-
tions were found in self-grooming (F(6,51)  4.48, p 	 0.01),
which also differed depending on time (F(3,51) 9.91, p	 0.01)
and treatment (F(2,17)  3.64, p  0.04). CRF-R1/2-agonist-
treated dams showed more self-grooming at t 0 min compared
with the previous time point and compared with VEH-treated
dams (p	 0.01 in each case).
Maternal motivation on LD2
In the PRT, a strong trend toward reduced pup retrieval in CRF-
R1/2-agonist-treated dams was observed (VEH: 3.3  1.5; Ucn:
0.4 0.3; D-Phe: 3.5 0.8 number of pups collected in 15 min;
one-way ANOVA; F(2,18) 3.23, p 0.06). No differences were
observed in CRF-R1/2-antagonist-treated dams.
Maternal aggression on LD5
The number of attacks did not differ between the groups even
though CRF-R1/2 agonist injection completely abolished mater-
nal aggression (Fig. 1C, top). However, the latency to the first
attack was significantly affected by the treatment (one-way
ANOVA; F(2,15)  3.93, p  0.04; Fig. 1C, bottom). The CRF-
R1/2 agonist significantly increased the attack latency compared
with VEH (p 0.05). No other behavioral parameter (e.g., keep
down, lateral threat, offensive upright) measured during the ma-
ternal defense test differed between the groups.
Anxiety-related behavior on LD3
The treatment tended to alter the percentage of time spent on the
open arms of the EPM (one-way ANOVA; F(2,16)  3.23, p 
0.06; Fig. 1D, top), whereas the percentage of open arm entries
was significantly altered by the treatment (F(2,16) 6.43, p	 0.01;
Fig. 1D, bottom). CRF-R1/2-agonist-infused dams made signifi-
cantly fewer entries into the open arms comparedwithVEH (p
0.02; Fig. 1D, bottom). Importantly, entries into closed arms did
not differ between the groups, indicating that the intracerebro-
ventricular infusion did not affect locomotor activity (data not
shown).
Experiment 2: Expression of CRF-R1 and CRF-R2mRNA in
the BNST of virgin versus lactating rats
CRF-R1 mRNA expression did not differ between virgin and
lactating rats in either themBNSTor the pBNST (Fig. 2). CRF-R2
mRNA expression was higher in the pBNST compared with the
mBNST (two-way ANOVA; factor: brain site; F(1,19) 12.05, p	
0.01; Fig. 2), but was not altered by the reproductive status nor
was an interaction found between the two factors. There was no
significant difference in the ratio of CRF-R1:R2 mRNA expres-
sion in either the mBNST (virgin 9.5 3.1; lactating 8.9
1.5) or the pBNST (virgin  2.7  0.5; lactating  2.8  0.1)
between virgin and lactating rats.
Experiment 3: Behavioral effects of intra-mpBNST CRF-R1 or
CRF-R2manipulation in lactating rats
The precise cannula placement sites within the mpBNST are il-
lustrated in Figure 3A. The slow infusion of 0.5 l spreads out
over an area of 1mm3, thusmainly affecting the pBNST, but also
the mBNST (Fig. 3B), which is consistent with previous findings
(Engelmann et al., 1999).
Maternal care under nonstress conditions on LD1
ABN. Differences in ABN were found depending on treatment
(two-way ANOVA for repeated measures; F(4,48)  3.33, p 
Table 2. Effects of nonspecific icv CRF-Rmanipulation on nonmaternal behaviors under stress conditions on LD 5
Behavior Group
Occurrence (n)
130 min 100 min  0 min 30 min
Off-nest VEH 0.0 0.0 1.7 1.3  8.5 1.7 2.2 1.3
CRF-R1/2 ago 0.3 0.3 1.5 0.6  10.0 1.5 5.2 1.8
CRF-R1/2 ant 0.9 0.4 2.8 1.2  8.5 1.3 4.6 2.0
Locomotion VEH 0.0 0.0 1.0 0.7  5.5 1.3 0.2 0.2
CRF-R1/2 ago 0.0 0.0 0.3 0.2  4.3 1.0 0.7 0.2
CRF-R1/2 ant 0.4 0.3 0.9 0.6  3.8 0.6 0.8 0.4
Self-grooming VEH 0.0 0.0 0.0 0.0  0.8 0.4 0.3 0.3
CRF-R1/2 ago 0.2 0.2 0.2 0.2  2.8 0.7** 0.5 0.3
CRF-R1/2 ant 0.4 0.3 0.5 0.3  0.5 0.3 0.5 0.3
Sleeping/resting VEH 0.0 0.0 0.0 0.0  0.0 0.0 1.0 0.6
CRF-R1/2 ago 0.2 0.2 0.3 0.3  0.5 0.3 2.7 1.7
CRF-R1/2 ant 0.0 0.0 0.3 0.3  1.3 0.9 2.6 1.7
ago, Agonist; ant, antagonist.
The occurrence of all off-nest behaviors was scored for 60min before and for 60min after the combined infusion with thematernal defense test (indicated by the dotted line). Off-nest behavior is further divided into locomotion (including
digging/burrowing and any explorative behavior in the home cage), self-grooming, and sleeping/resting. For details on treatments, see legend to Figure 1. Data are presented asmean SEM. n 6–7 per group. **p 0.01 versus VEH;
p 0.01 versus previous time point (two-way ANOVA for repeated measures; factors: time treatment).
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0.01), but not on time. However, there was a significant time 
treatment interaction (F(24,288)  1.57, p  0.04; Fig. 4A, top).
Before the infusion, no differences were detected between the
groups. Shortly afterward, dams treated with the CRF-R1 agonist
showed less ABN at t30 min and t60 min (p 0.03 in each
case) compared with VEH-treated dams. During the observation in
the afternoon, lessABNwasobserved inCRF-R1-antagonist-treated
dams at t300min and inCRF-R2-agonist-treated dams at t300
min and t330min compared with VEH (p	 0.01 in each case).
Nursing. Differences in nursing were found depending on
time (two-wayANOVA for repeatedmeasures; F(6,24) 2.85, p
0.01) and on treatment (F(4,48)  4.24, p 	 0.01). Moreover, a
Figure 2. CRF-R1 (top) and CRF-R2 (bottom) mRNA expression in the medial and posterior part of the BNST comparing virgin and lactating rats. Data are presented as mean grain area SEM.
n 4–7 per group. ** p 0.01 versusmedial part (two-way ANOVA; factors: reproductive status brain site). Representative photomicrographs from a lactating rat are shown on the right side
(4 objective) Scale bar, 500m. Hybridization is evident as localized clumps of silver grains. ac, Anterior commissure.
Figure 3. Histological localization of infusion cannula within the mpBNST. A, Cannula placement sites for subsequent drug infusion are shown as black dots within the mpBNST on schematic
plates from the Paxinos andWatson (1998) stereotaxic atlas. B, Extent of substance spreading after ink infusion (black dot) in three rats is shown schematically as gray circles within the mpBNST.
ac, Anterior commissure; f, fornix; ic, internal capsule; lv, lateral ventricle; sm, stria medullaris of the thalamus.
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significant time treatment interaction was revealed (F(24,288)
1.69, p  0.02; Fig. 4A, bottom). Before the infusion, no differ-
ences were found. Shortly afterward, theCRF-R1-agonist-treated
dams showed less nursing at t30min (p	 0.01) and t60min
(p  0.05) compared with VEH. During the observation in the
afternoon, the CRF-R2 agonist resulted in significantly less nurs-
ing at t 300 min (p  0.03) and t 330 min (p 	 0.01) com-
pared with VEH.
Other maternal behaviors. No significant differences or inter-
actions depending on time and/or treatment were found in pup
retrieval/mouthing and licking/grooming (data not shown). We
did not observe any pup killing after any of the treatments.
Nonmaternal behaviors. Significant interactions were found in
the occurrence of off-nest behavior (two-way ANOVA for re-
peated measures; F(24,288) 1.62, p 0.03; Table 3), which also
differed depending on time (F(6,288) 3.14, p	 0.01) and treat-
ment (F(4,48)  3.20, p  0.02). CRF-R1- and CRF-R2-agonist-
treated dams showed off-nest behavior more frequently
compared with the respective previous time point (p 	 0.01 in
each case) and compared with VEH at t30 min (CRF-R1 ago-
nist: p	 0.01, CRF-R2 agonist: p 0.01). In addition, CRF-R2-
agonist-treated dams displayed more off-
nest behaviors at t330 min (p 0.01).
Differences in locomotion were found de-
pending on time (F(6,288)  8.05, p 	
0.01), but not on treatment. However, a
significant interaction was detected
(F(24,288)  2.78, p 	 0.01). CRF-R1-
agonist-treated dams showed more loco-
motion compared with the previous time
point and compared with VEH at t 30
min (p 	 0.01 in each case). CRF-R2-
agonist-treated dams showed more loco-
motion at t 330 min compared with
VEH (p  0.05). Differences in self-
grooming were found depending on time
(F(6,288)  8.56, p 	 0.01), but not on
treatment. However, a significant interac-
tion was detected (F(24,288)  3.15, p 	
0.01). CRF-R1 (p 	 0.01) and CRF-R2-
agonist-treated dams (p  0.02) showed
more self-grooming at t 30 min com-
pared with the respective previous time
point. In addition, CRF-R1-agonist-
treated dams showed more self-
grooming at t30 min (p	 0.01), as did
CRF-R1-antagonist-treated dams at t
330min compared with VEH. CRF-R2-
antagonist-treated dams showed less self-
grooming at t 90 min (p  0.05).
Differences in sleeping/resting were
found depending on time (F(6,288) 4.72,
p 	 0.01) and treatment (F(4,48)  3.89,
p 	 0.01). However, no significant inter-
action was detected. CRF-R2-agonist-
treated dams showed more sleeping/
resting at t 30 min compared with the
previous time point (p 	 0.01) and at t
300 min (p  0.01) and t 330 min
(p	 0.01) compared with VEH.
Maternal care under stress conditions
on LD5
ABN. Differences in ABN depending on
time (two-way ANOVA for repeated measures; factor: time;
F(3,120) 4.64, p	 0.01) and treatment (factor: treatment; F(4,40)
 4.17, p 	 0.01) were detected (Fig. 4B, top); however, no
interaction effect was found. Although no differences in ABN
were found before anymanipulation, the infusion pairedwith the
maternal defense test led to a significant reduction in the occur-
rence of ABN in the VEH group (t100 min versus t 0 min; p
0.01). Only the CRF-R2-antagonist-treated dams showed more
ABN at t 30 min (p  0.04) compared with the VEH-treated
dams.
Nursing. Differences in nursing were found depending on
time (ANOVA for repeated measures; F(3,120)  9.57, p 	 0.01;
Fig. 4B, bottom), but not on treatment, nor was an interaction
effect detected. However, single analysis of the time courses
within the different treatment groups revealed main effects in
VEH-treated dams (one-way ANOVA for repeated measures;
F(3,33)  4.29, p  0.01) and CRF-R1-agonist-treated dams
(F(3,21)  3.6, p  0.03), as well as a trend in CRF-R2 agonist-
treated dams (F(3,18) 2.53, p 0.08). The occurrence of nursing
was decreased at t30min comparedwith prestress levels (VEH:
Figure 4. Effect of intra-mpBNST CRF-R1 or CRF-R2 specific agonist (ago) or antagonist (ant) treatment on maternal care of
lactating dams under nonstress conditions on LD1 (A) and stress conditions on LD5 (B). ABN (top) and sum of nursing (bottom)
were scored for 60 min before and for 90 min after infusion (A) or 60 min after maternal defense (B). Under nonstress conditions,
ABN and nursingwere also observed for additional 60min in the afternoon (A). Dams received an acute bilateral infusion of VEH (5
l of sterile Ringer’s solution; pH 7.4), CRF-R1 agonist human/rat CRF (CRF-R1 ago; 1g/0.5l), CRF-R1 antagonist CP-154,526
(CRF-R1 ant; 12g/0.5l), CRF-R2 agonist stresscopin (CRF-R2 ago; 3g/0.5l), or CRF-R2 antagonist Astressin-2B (CRF-R2
ant; 4g/0.5l) into thempBNST. Data are presented asmean SEM. n 8–14 per group. **p 0.01, *p 0.05 versus VEH
(two-way ANOVA for repeated measures; factors: time treatment);p 0.05, () p 0.08 versus t100 min (one-way
ANOVA for repeated measures; factor: time).
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t 0 min vs t130 min: p 0.01, t 0 min vs t100 min: p 0.06;
CRF: t 0min vs t130min: p 0.03, t 0min vs t100min: p
0.05). Treatment with either the CRF-R1 or CRF-R2 antagonist
prevented this stress-induced reduction in nursing.
Other maternal behaviors. No significant differences or inter-
actions depending on time and/or treatment were found in pup
retrieval/mouthing and licking/grooming (data not shown). We
did not observe any pup killing after any of the treatments.
Nonmaternal behaviors. Dams differed in the occurrence of
off-nest behavior (F(3,126)  8.59, p 	 0.01; Table 4), self-
grooming (F(3,126) 7.33, p	 0.01), and locomotion (F(3,126)
16.52, p 	 0.01) depending on time. However, no treatment or
interaction effects were observed. For locomotion, a strong trend
for an interaction was detected (F(12,126)  1.76, p  0.06). No
differences were found in sleeping/resting.
Maternal motivation on LD2
None of the treatments affected pup retrieval behavior (pups
retrieved within 15 min: VEH: 7.3 0.5; CRF-R1 agonist: 7.0
1.0; CRF-R1 antagonist: 8.0  0.0; CRF-R2 agonist: 5.3  2.7;
CRF-R2 antagonist: 2.8 1.5).
Maternal aggression on LD5
The number of attacks (one-way ANOVA; F(4,39)  5.53, p 
0.01; Fig. 5, left) and the attack latency (F(4,39) 10.16, p	 0.01;
Table 3. Effects of specific intra-mpBNST CRF-Rmanipulation on nonmaternal behaviors under nonstress conditions on LD 1
Behavior Group
Occurrence (n)
60 min 30 min  30 min 60 min 90 min 300 min 330 min
Off-nest VEH 0.4 0.1 1.0 0.6  1.3 1.0 0.9 0.7 2.3 1.2 0.3 0.2 0.5 0.4
CRF-R1 ago 1.1 0.7 0.6 0.6  6.6 1.4** 1.4 0.5 0.5 0.3 1.9 1.7 0.6 0.6
CRF-R1 ant 0.0 0.0 1.7 1.0  2.0 1.3 1.7 1.3 0.5 0.2 1.7 1.2 2.5 1.4
CRF-R2 ago 1.4 0.6 1.2 0.6  5.3 1.8* 2.8 1.6 1.9 0.9 3.3 1.7 4.8 2.2*
CRF-R2 ant 1.3 0.7 0.7 0.4  0.5 0.2 1.7 0.7 1.2 0.9 1.4 1.1 0.2 0.2
Locomotion VEH 0.3 0.1 0.3 0.2  0.1 0.1 0.0 0.0 0.4 0.3 0.2 0.1 0.0 0.0
CRF-R1 ago 0.5 0.4 0.1 0.1  3.9 1.0** 1.0 0.3 0.1 0.1 0.1 0.1 0.0 0.0
CRF-R1 ant 0.0 0.0 1.1 0.7  1.6 1.2 1.0 0.7 0.2 0.2 0.3 0.1 0.2 0.1
CRF-R2 ago 0.4 0.2 1.1 0.7  1.4 0.6 0.8 0.4 0.2 0.1 0.1 0.1 0.2 0.1*
CRF-R2 ant 0.4 0.2 0.4 0.2  0.2 0.1 0.5 0.3 0.7 0.5 0.0 0.0 0.0 0.0
Self-grooming VEH 0.1 0.1 0.3 0.3  0.3 0.3 0.3 0.2 0.4 0.2 0.2 0.2 0.0 0.0
CRF-R1 ago 0.1 0.1 0.1 0.1  2.0 0.5** 0.4 0.3 0.1 0.1 0.1 0.1 0.0 0.0
CRF-R1 ant 0.0 0.0 0.2 0.1  0.1 0.1 0.2 0.2 0.3 0.2 0.1 0.1 0.3 0.1*
CRF-R2 ago 0.2 0.1 0.0 0.0  0.9 0.4 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1
CRF-R2 ant 0.2 0.2 0.1 0.1  0.2 0.1 0.2 0.2 0.0 0.0* 0.1 0.1 0.0 0.0
Sleeping/resting VEH 0.0 0.0 0.0 0.0  0.6 0.6 0.0 0.0 1.3 1.3 0.0 0.0 0.0 0.0
CRF-R1 ago 0.0 0.0 0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.6 0.6 0.6
CRF-R1 ant 0.0 0.0 0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.1 1.9 1.4
CRF-R2 ago 0.0 0.0 0.0 0.0  2.1 1.4 1.4 1.4 1.0 0.7 4.7 2.1** 4.4 2.2**
CRF-R2 ant 0.0 0.0 0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.1 0.2 0.2
ago, Agonist; ant, antagonist.
The occurrence of all off-nest behaviors was scored for 60 min before and 90 min after infusion (indicated by the dotted line), as well as for 60 min in the afternoon (last 2 columns). Off-nest behavior is further divided into locomotion
(including digging/burrowing and any explorative behavior in the home cage), self-grooming, and sleeping/resting. For details on treatments, see legend to Figure 4. Data are presented asmean SEM. n 8–14 per group. **p 0.01,
*p 0.05 versus VEH;p 0.01,p 0.05 versus previous time point (two-way ANOVA for repeated measures; factors: time treatment).
Table 4. Effects of specific intra-mpBNST CRF-Rmanipulation on nonmaternal behaviors under stress conditions on LD 5
Behavior Group
Occurrence (n)
130 min 100 min  0 min 30 min
Off-nest VEH 2.4 1.1 4.1 1.5  6.3 1.7 4.0 1.6
CRF-R1 ago 3.9 2.2 3.5 1.8  8.3 2.0 4.9 2.0
CRF-R1 ant 1.1 0.6 3.1 0.8  5.4 2.0 1.7 0.9
CRF-R2 ago 1.6 1.3 3.3 1.5  5.4 1.5 2.7 1.6
CRF-R2 ant 3.0 1.1 1.7 0.7  3.8 1.2 2.2 1.3
Locomotion VEH 0.2 0.1 0.5 0.3  2.5 0.8 0.7 0.3
CRF-R1 ago 1.5 1.1 0.8 0.5  4.6 1.4 0.9 0.5
CRF-R1 ant 0.3 0.2 1.3 0.7  3.0 1.2 1.1 0.6
CRF-R2 ago 0.2 0.1 1.7 0.9  1.7 0.4 0.6 0.3
CRF-R2 ant 1.3 0.5 0.5 0.3  1.7 0.6 0.5 0.2
Self-grooming VEH 0.6 0.3 1.0 0.6  1.7 0.5 0.3 0.2
CRF-R1 ago 0.1 0.1 0.4 0.2  1.1 0.5 1.0 0.4
CRF-R1 ant 0.1 0.1 0.7 0.4  2.0 1.6 0.6 0.4
CRF-R2 ago 0.1 0.1 0.3 0.3  1.1 0.4 0.0 0.0
CRF-R2 ant 0.4 0.2 0.5 0.5  0.7 0.3 0.0 0.0
Sleeping/resting VEH 0.3 0.3 0.2 0.1  0.8 0.6 2.4 1.6
CRF-R1 ago 0.0 0.0 1.6 1.6  1.3 1.1 2.8 2.0
CRF-R1 ant 0.1 0.1 0.0 0.0  0.0 0.0 0.0 0.0
CRF-R2 ago 1.0 1.0 0.4 0.4  1.4 1.1 1.6 1.3
CRF-R2 ant 0.0 0.0 0.0 0.0  0.9 0.7 1.2 1.2
ago, Agonist; ant, antagonist.
The occurrence of all off-nest behaviors was scored for 60 min before and 60 min after the combined infusion with the maternal defense test (indicated by the dotted line). Off-nest behavior is further divided into locomotion (including
digging/burrowing and any explorative behavior in the home cage), self-grooming, and sleeping/resting. For details on treatments, see legend to Figure 4. Data are presented as mean SEM. n 8–14 per group.
9672 • J. Neurosci., July 16, 2014 • 34(29):9665–9676 Klampfl et al. •mpBNST CRF-R Activation Impairs Maternal Behavior
Fig. 5, right) differed between the groups. The CRF-R2 agonist
completely blocked attacks (p  0.02) and thus increased the
attack latency (p	 0.01) compared with the VEH-treated dams.
Accordingly, the CRF-R2 antagonist increased the number of
attacks (p  0.02) and decreased the attack latency (p  0.03).
Neither the CRF-R1 agonist nor antagonist had any significant
effect on maternal aggression. No other behavioral parameters
(e.g., keep down, lateral threat, offensive upright) measured dur-
ing maternal defense differed between the groups.
Anxiety-related behavior on LD3
Treatment significantly altered the percentage of time spent on
the open arms of the EPM in the lactating dams (one-way
ANOVA; F(4,43)  16.21, p 	 0.01; Fig. 6, left). Mothers treated
with the CRF-R1 agonist spent significantly less time in the open
arms (p  0.04), whereas dams injected with the antagonist for
CRF-R1 (p 	 0.01) or CRF-R2 (p 	 0.01) spent significantly
more time on the open arms compared with the VEH-treated
dams. CRF-R2-agonist-infusedmothers did not significantly dif-
fer fromVEH-treatedmothers. Regarding locomotor activity, no
group differences were detected in number of entries into the
closed arms (data not shown).
Experiments 4 and 5: Behavioral effects of intra-mpBNST
CRF-R1 or CRF-R2 blockade on anxiety in virgin andmale
rats
Virgin rats
The percentage of time spent on the open arms of the EPM sig-
nificantly differed depending on the treatment (one-way
ANOVA; F(2,11) 7.03, p 0.01; Fig. 6A). Females treated with
the CRF-R1 antagonist (p  0.03) or the CRF-R2 antagonist
(p	 0.01) spent significantly more time on the open arms com-
pared with the VEH-treated females. No difference was found in
the number of closed arm entries between any of the groups (data
not shown).
Male rats
No statistically significant differences were found in any of the
parameters tested in male rats either on the EPM or in the LDB
when infused with subtype-specific CRF-R agonists or antago-
nists (Fig. 6B).
Discussion
This is the first study to provide evidence that CRF-R2 and, to a
lesser extent, CRF-R1 in thempBNST are important in regulating
maternal behavior in lactating rats. CRF-R2, but not CRF-R1,
mRNA expression was higher in the pBNST versus mBNST in-
dependently of reproductive status (Fig. 2). The behavioral ex-
periments revealed that ABN and total nursing were rapidly
impaired by intra-mpBNST CRF-R1 agonist and after a delay by
the CRF-R2 agonist. However, under stress conditions, ABNwas
increased only by the CRF-R2 antagonist, whereas both antago-
nists prevented the typical decrease in nursing after stress (Fig. 4).
During the maternal defense test, the CRF-R2 agonist abolished
maternal aggression, whereas the CRF-R2 antagonist increased
aggression; however, CRF-R1 manipulation had no significant
effect (Fig. 5). Furthermore, the CRF-R1 agonist increased,
whereas both antagonists decreased, anxiety-related behavior in
virgin and lactating rats, but not in male rats (Fig. 6).
Several studies suggest a crucial contribution of CRF in regu-
lating cellular (Lightman et al., 2001;Walker et al., 2001; da Costa
et al., 2001; Deschamps et al., 2003) and behavioral adaptations
(Pedersen et al., 1991; Gammie et al., 2004; Klampfl et al., 2013)
in lactating females. We demonstrated recently that activation of
central CRF-R1/2 reduces, and their blockade increases,maternal
behavior, whereas anxiety was altered conversely (Klampfl et al.,
2013). Because the previously infused agonist CRF binds with
40-fold higher affinity to CRF-R1 (Hauger et al., 2003), it is often
used as a CRF-R1-specific agonist (e.g., Magalhaes et al., 2010).
Therefore, we aimed to confirm our earlier results using the non-
specific CRF-R1/2 agonist Ucn 1 (Fig. 1). Importantly, the behav-
ioral effects were similar to our recent data (Klampfl et al., 2013)
and also support previous studies demonstrating a detrimental
effect of CRF-R activation on maternal behavior (Pedersen et al.,
1991; Gammie et al., 2004; Klampfl et al., 2013). Consistent with
our findings in rats, intracerebroventricular Ucn 1 impairs ma-
ternal aggressive behavior in lactatingmice (D’Anna et al., 2005).
Furthermore, Ucn 1 is known to be anxiogenic in male rodents
(Moreau et al., 1997; Spina et al., 2002), which we now extend to
lactating rats (Fig. 1). These results confirm the impairing effects
of central CRF-R activation on maternal behavior and postpar-
tum anxiety.
We further focused on the BNST due to its importance in
mediating maternal care (Numan and Insel, 2003), maternal ag-
gression (Bosch et al., 2010; Bosch, 2011; Caughey et al., 2011),
and anxiety (Sahuque et al., 2006; Walker et al., 2009). Impor-
tantly, the BNST contains most members of the CRF family, in-
cluding CRF (Potter et al., 1994), Ucn 2 (Reyes et al., 2001), and
Ucn 3 (Lewis et al., 2001), as well as CRF-R1 and CRF-R2 (Potter
et al., 1994; Chalmers et al., 1995). We found no differences in
either CRF-R1 or CRF-R2 mRNA within the mBNST or the
pBNST between virgin and lactating rats (Fig. 2). However,
CRF-R2 mRNA expression was higher in the pBNST compared
with the mBNST. Therefore, we hypothesize that CRF-R2 might
play a special role in the pBNST, but that CRF-R1 could contrib-
ute equally to possible behavioral changes.
Intra-mpBNST application of either the CRF-R1 or CRF-R2
antagonist had no effect on nursing behavior under nonstress
conditions. This indicates a minimal activation of the CRF-R
under basal conditions during lactation and thus strengthens the
hypothesis that downregulation of the CRF system in the mater-
nal brain is vital. However, infusion of either agonist reduced
nursing behavior in a time-dependent manner: the effects of the
CRF-R1 agonist were rapid, whereas those of the CRF-R2 agonist
were delayed. At the same time, the dams displayedmore off-nest
behaviors; CRF-R1-agonist-treated dams showed more locomo-
tion and self-grooming, whereas CRF-R2-agonist-treated dams
showed more sleeping/resting (Table 3). The time-delayed effect
Figure5. Effect of intra-mpBNST CRF-R1 or CRF-R2 specific agonist (ago) or antagonist (ant)
treatment on maternal aggression of lactating rats measured in the maternal defense test.
Maternal aggression against a virgin female intruder was scored during the 10 min trial. Num-
ber of attacks (left) and attack latency (right) by the resident is shown. For details on treat-
ments, see legend to Figure 4. Data are presented asmean SEM.n7–11per group. **p
0.01, *p 0.05 versus VEH (one-way ANOVA; factor: treatment).
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of the CRF-R2 agonist might be due to a
longer latency until the agonist exerts its
actions under basal conditions (Pelley-
mounter et al., 2004; D’Anna et al., 2005;
D’Anna and Gammie, 2009). Therefore,
the relative quiescence of both receptor
subtypes in the mpBNST is necessary for
the expression of appropriate maternal
care under basal conditions. Because
CRF-R mRNA expression was not differ-
ent (Fig. 2) and CRF mRNA levels are el-
evated in the pBNST compared with
virgin females (Walker et al., 2001), the
proposed quiescence could result from ei-
ther reducedCRF-R protein expression or
reduced CRF/Ucn release. This might re-
sult from reduced noradrenergic input to
the BNST (Forray and Gysling, 2004) or
reduced noradrenergic activity within the
BNST (Smith et al., 2012) postpartum. In
addition, increased oxytocin receptor
binding within the BNST postpartum
(Bosch et al., 2010) might attenuate the
activity of CRF neurons, as has been
shown for the paraventricular nucleus
(Windle et al., 2004) and, moreover, has
been proposed recently for the BNST (Da-
browska et al., 2013). Furthermore, CRF
neurons projecting to the BNST from the
central amygdala express reduced levels of
CRFmRNA during lactation (Walker et al., 2001), thus support-
ing reduced CRF-R activation also within the mpBNST.
However, after stressor exposure, distinct roles for CRF-R1
and CRF-R2 emerged during subsequent maternal care observa-
tion. ABN reflecting the quality ofmaternal care returned rapidly
to prestress levels only in the CRF-R2-antagonist-treated group.
The occurrence of nursing reflecting the quantity of maternal
care was affected by both receptor antagonists, because a small
but significant decrease in nursing after the maternal defense test
was prevented by intra-mpBNST administration of both the
CRF-R1 and CRF-R2 antagonist.
In contrast to maternal care, we did not find any changes in
maternal motivation after subtype-specific CRF-R manipula-
tions within the mpBNST. This seems to be contrary to our own
results, because we showed a trend for reducedmaternal motiva-
tion in the CRF-R1/2-agonist-treated rats (Experiment 1). How-
ever, one has to distinguish between central—and thus very
broad—receptormanipulation versus local agonism/antagonism
of CRF-R within the mpBNST (Bosch, 2011). Because the BNST
has not been reported tomediatematernalmotivation, the lack of
an effect after intra-mpBNST manipulation was anticipated.
With respect to maternal aggression, activation and blockade
of CRF-R2 (but not CRF-R1) abolished and increased maternal
aggression, respectively (Fig. 5). Interestingly, the CRF-R2 ago-
nist elicited an immediate behavioral effect in a stressful situa-
tion, in contrast to basal conditions. These findings support our
hypothesis that CRF-R activation in thempBNSTneeds to be low
during lactation for appropriate maternal behavior to occur. In
addition, this further highlights the importance of the CRF-R2
subtype in the regulation of maternal behavior. Consistent with
this, CRF-R2, but not CRF-R1, within the lateral septummediate
maternal aggression in lactating mice (Gammie et al., 2005;
D’Anna and Gammie, 2009). Therefore, signal transmission via
CRF-R2 modulates maternal aggressive behavior, at least within
the mpBNST and the lateral septum.
In addition to maternal behavior, manipulation of CRF-R
activity within the mpBNST also affected anxiety-related behav-
ior (Fig. 6). Activation of CRF-R1was anxiogenic, whereas block-
ade of CRF-R1 or CRF-R2 was anxiolytic in dams. Interestingly,
CRF-R1 activation in lactating rats was anxiogenic at a dose that
was not effective in male rats. However, a 2.5-fold higher dose
elicits an anxiogenic effect in males (S.M.K. and O.J.B., unpub-
lished data), thereby confirming a previous study showing a sim-
ilar dose-dependent effect on anxiety (Sahuque et al., 2006). This
suggests a higher activation threshold in males. Furthermore, the
CRF-R1orCRF-R2 antagonists reduced anxiety-related behavior
in the lactating females, but not in males, which indicates that
these antagonists have anxiolytic actions only in combination
with previous activation of the receptor in males (Sahuque et al.,
2006). Interestingly, the anxiolytic effects of both antagonists
were also found in virgin rats, suggesting a higher basal activity of
intra-mpBNST CRF-R in females. Therefore, the higher basal
activity and the lower activation threshold in females renders the
system more sensitive and potentially vulnerable, as shown for
the locus ceruleus (Valentino et al., 2013). Interestingly, a recent
study demonstrated that CRF infusions into the dorsal raphe
nucleus of femalemice had no effect, whereas the same treatment
affected anxiety in males (Howerton et al., 2014). However, our
study is the first to provide evidence that the regulation of emo-
tionality within the BNST by the CRF system is sexually dimor-
phic and independent of reproductive status.
Regarding the lack of effect on anxiety-related behavior after
CRF-R2 activation with stresscopin in lactating rats, it is possible
that the dose used was subthreshold or that the agonist requires
more time to elicit an anxiogenic-like response. Indeed, the
CRF-R2 ligand Ucn 2, which shares high homology with stress-
Figure 6. Effect of intra-mpBNST CRF-R1 or CRF-R2 specific agonist (ago) or antagonist (ant) treatment on anxiety-related
behavior of lactating and virgin female (A) andmale rats (B) on the EPMor the LDB (males only). Virgin femaleswere treatedwith
antagonists only. The percentage of time spent on the open arms or the percentage of time spent in the light box during the 5min
tests is shown. For details on treatments, see legend to Figure 4. Data are presented asmean SEM. n 7–12 per group. **p	
0.01, *p 0.05 versus VEH (one-way ANOVA; factor: treatment).
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copin and bindswith similar high affinity toCRF-R2 (Reyes et al.,
2001), exerts its anxiogenic effect only 4 h after central infusion in
male rats (Pelleymounter et al., 2002; Valdez et al., 2002; Pelley-
mounter et al., 2004). The role of CRF-R2 in anxiety-related
behavior appears to be complex, especially with respect to CRF-
R2-knock-out mice (Reul and Holsboer, 2002). The region- and
neuron-specific location of receptors, and thus the differential
modulation of neurotransmitter systems, is likely responsible for
an anxiogenic or anxiolytic behavioral outcome after CRF-R2
activation.
In conclusion, low CRF-R activation within the mpBNST
postpartum is an indispensable prerequisite for the adequate
rearing and defense of the offspring. Because dysregulation of the
mother’s CRF system is evident in postpartum mood disorders,
our findings serve to better understand the fine-tuned regulation
of the maternal brain, especially under stressful conditions.
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